AzTrials
AzTrials

Postoperative PainNCT07709975

Analgesia Methods and Early Mobilization in Geriatric ICU Patients After Major Surgery

An observational study of Postoperative Pain and Delirium - Postoperative, run by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study looks at how different pain-control methods affect how quickly older adults get out of bed and start moving again after major surgery. Researchers will observe patients aged 65 and older who are admitted to the intensive care unit (ICU) after major surgery. Read more about this study

Who is it for?
Ages 65 years and older
What is being tested?
Systemic Opioid Analgesia (± Multimodal), Epidural Analgesia and Peripheral Nerve Block (± Multimodal)
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Jun 2026to 15 Sep 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Patients aged 65 years and older admitted to the intensive care unit after major surgery at a single tertiary care center, receiving one of three standard-of-care postoperative analgesia approaches (systemic, epidural, or peripheral nerve block) as determined by the treating clinical team.

Who may be able to join

  • Age 65 years or older
  • ASA physical status classification I-IV
  • Admitted to the intensive care unit (ICU) following major surgery
  • ICU stay of at least 24 hours

Who cannot join

  • Previously diagnosed advanced-stage dementia
  • Inability to assess consciousness due to severe neurological deficit
  • ICU stay of less than 24 hours
  • Incomplete or insufficient clinical data

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Zekeriya Ervatan, MD contact

+90505 598 32 48

zek.ervatan@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • University of Health Sciences, Prof. Dr. Cemil Taşçıoğlu City Hospital

    Istanbul, Istanbul, 34384

    Zekeriya Ervatan, MD, +90505 598 32 48, zek.ervatan@gmail.com

    Beyzanur Aydoğdu, MD, +90531 367 70 76, beyzaaydogan7714@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Analgesia Methods on Early Mobilization and Patient Satisfaction in Geriatric Patients Admitted to Intensive Care After Major Surgery

This study looks at how different pain-control methods affect how quickly older adults get out of bed and start moving again after major surgery. Researchers will observe patients aged 65 and older who are admitted to the intensive care unit (ICU) after major surgery. Doctors will use their usual pain-control methods - either medication given through a vein, an epidural, or a nerve block - based on standard clinical practice; the study team will not change or choose the treatment. The study will record how long it takes for each patient to first sit up, stand, or walk after surgery, along with pain levels, confusion (delirium), how satisfied patients are with their pain control, and how long they stay in the ICU. The goal is to better understand which pain-control approaches may help older patients recover and move more quickly and safely after major surgery.

Read the detailed description

Early mobilization is a key component of enhanced postoperative recovery in older adults and has been associated with reduced functional decline, shorter intensive care unit (ICU) and hospital stays, and fewer postoperative complications. However, postoperative pain remains one of the main barriers to early mobilization. Although several analgesic strategies are routinely used after major surgery, their comparative effects on functional recovery in critically ill geriatric patients have not been well established in real-world clinical practice.

This is a prospective, single-center observational cohort study designed to evaluate the association between routinely administered postoperative analgesic techniques and early postoperative recovery in geriatric surgical patients requiring ICU admission. Because the study is observational, all perioperative and postoperative management, including the choice of analgesic technique, will be determined exclusively by the treating clinicians according to institutional practice. No treatment allocation, randomization, or protocol-driven intervention will be performed.

Clinical and perioperative data will be collected prospectively from routine medical records, anesthesia documentation, ICU electronic records, and nursing charts using standardized case report forms. Data quality will be ensured through predefined data collection procedures and verification before database entry. The study does not require any additional diagnostic tests, invasive procedures, blood sampling, or alterations to routine patient care.

The findings are expected to provide real-world evidence regarding the relationship between commonly used postoperative analgesic strategies and recovery after major surgery in older adults. These results may help optimize perioperative pain management protocols and support future comparative and interventional studies aimed at improving functional recovery in the geriatric surgical population.

Being tested
Systemic Opioid Analgesia (± Multimodal), Epidural Analgesia, Peripheral Nerve Block (± Multimodal)
Keywords
Geriatric, Intensive Care Unit, Major Surgery, Postoperative Analgesia, Early Mobilization, Epidural Analgesia, Peripheral Nerve Block, Opioid Consumption, Delirium, CAM-ICU, Patient Satisfaction, Frailty
Medical subject headings
Pain, Postoperative, Emergence Delirium, Frailty, Delirium, Patient Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Systemic Opioid Analgesia (± Multimodal)Drug

    Standard-of-care intravenous opioid-based analgesia, with or without additional non-opioid multimodal agents, administered per routine clinical practice.

  • Epidural AnalgesiaProcedure or surgery

    Standard-of-care epidural analgesia administered per routine clinical practice.

  • Peripheral Nerve Block (± Multimodal)Procedure or surgery

    Standard-of-care peripheral nerve block analgesia, with or without additional non-opioid multimodal agents, administered per routine clinical practice.

Study groups in NCT07709975
Study groupRoleWhat they receive
Systemic AnalgesiaPatients who receive systemic (intravenous) opioid analgesia, with or without multimodal analgesic agents, as determined by the treating clinical team.
Receives: Drug: Systemic Opioid Analgesia (± Multimodal)
Epidural AnalgesiaPatients who receive epidural analgesia as determined by the treating clinical team.
Receives: Procedure: Epidural Analgesia
Peripheral Nerve BlockPatients who receive peripheral nerve block analgesia, with or without multimodal analgesic agents, as determined by the treating clinical team.
Receives: Procedure: Peripheral Nerve Block (± Multimodal)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to First Mobilization

    Time (in hours) from ICU admission to the first time the patient achieves at least one level of mobilization - sitting at the bedside, standing, or walking - based on the ICU Mobility Scale.

    Measured: From ICU admission until first achievement of ICU Mobility Scale level ≥1, assessed for up to 30 days.

Secondary outcomes (6)
  1. Postoperative Pain Score

    Pain intensity assessed using the Numeric Rating Scale (0 = no pain, 10 = worst possible pain).

    Measured: At ICU admission, and at 6, 12, 24, and 48 hours after ICU admission

  2. Incidence of Delirium

    Presence of delirium assessed using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU), reported as positive or negative.

    Measured: Assessed at least once daily for the first 3 days of ICU stay

  3. Length of ICU Stay

    Total number of days the patient remains in the intensive care unit.

    Measured: From ICU admission to ICU discharge, up to approximately 30 days

  4. Total Opioid Consumption

    Cumulative opioid dose administered, expressed as morphine milligram equivalents (mg).

    Measured: From ICU admission to ICU discharge, up to approximately 30 days

  5. Patient Satisfaction with Analgesia

    Patient-reported satisfaction with pain management assessed using a 5-point Likert scale (1 = very dissatisfied, 5 = very satisfied).

    Measured: Assessed once, prior to ICU discharge

  6. Incidence and Type of Postoperative Complications

    Presence and type of any postoperative complications recorded during ICU stay.

    Measured: From ICU admission to ICU discharge, up to approximately 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2026
  2. Study start15 Jun 2026
  3. Primary completion15 Sep 2026 (estimated)
  4. Study completion15 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07709975
Sponsor's protocol ID
CT-ERHO-AR-BA-04
Other IDs
E-48670771-514.99-316163880
Status last verified
Jul 2026
First submitted
11 Jul 2026
Last updated
17 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Pain and Delirium - Postoperative, run by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zekeriya Ervatan, MD (+90505 598 32 48, zek.ervatan@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to First Mobilization (time frame: From ICU admission until first achievement of ICU Mobility Scale level ≥1, assessed for up to 30 days.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in